Published July 9, 2015
| Version v1
Patent
Open
BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATION
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein. Such pharmaceutical composition may be used for treating and preventing opioid-induced side effects in patients, and may be provided to chronic opioid users as well.
Files
US20150190523.pdf
Files
(1.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:700c23183f1e8e13b9faf32ae6557183
|
1.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201314398914 A
- Patent application number
- US 2015/0190523 A1
- Other
- oai:uchicago.tind.io:9403
Dates
- Patent filed
-
2013-03-13